In the News

Share
Print
1753 News Items found
In the Clinic
Physician-scientist Charles Rudin
Unexpected Finding Reveals New Target for Aggressive Form of Lung Cancer
Researchers discover that a subset of lung adenocarcinomas are aggressive because of mutations that allow them to block ferroptosis, a type of cell death.
Structure of an intermediate during the homologous recombination reaction.
Wielding Powerful Imaging Tools, MSK Researchers Decipher Process of DNA Repair
The high-resolution views provided by cryo-electron microscopy are helping scientists learn how proteins and DNA collaborate to repair broken DNA.
MSK physician-scientists Nadeem Riaz and Jorge Reis-Filho.
For People with Certain BRCA Mutations, Activating the Immune System Could Be Promising Treatment
Human data and results from mouse experiments suggest that people with BRCA2 mutations may respond well to immunotherapy drugs.
In the Clinic
Medical oncologist Alexander Drilon
A Perfect Match: Molecular Tests Developed at MSK Guide Personalized Treatment for Lung Cancer
For personalized treatment to work, it’s important to analyze each person’s tumor for genetic mutations and find the best drugs to target those mutations.
Finding
Systems biologist Joao Xavier in his lab
MSK Study Is the First to Link Microbiota to Dynamics of the Human Immune System
MSK researchers have shown for the first time that the concentration of different types of immune cells in the blood changes in relation to the presence of different bacterial strains in the gut.
MSK Kid, Rihanna, and her family visit New York City to see her billboard.
Grateful for MSK Kids: Giving Thanks to MSK’s Youngest Patients
As we reflect in this season of gratitude, MSK Kids, the pediatric cancer program at Memorial Sloan Kettering, is grateful for our pediatric patients and their families. Patients just like Rihanna.
In the Lab
SKI cell biologists Junmei Yi and Xuejun Jiang
More Evidence that Cellular ‘Death by Iron’ Could Be Promising Avenue of Cancer Treatment
Cancers with certain mutations are vulnerable to ferroptosis, a form of iron-dependent cell death.
Aaron Mitchell, MD, MPH, a medical oncologist and health services researcher in the Department of Epidemiology and Biostatistics
Researchers  Review Physician Prescribing Practices Across a Wide Range of Specialties
Researchers at Memorial Sloan Kettering Cancer Center (MSK), have published the first systemic review of the association between industry payments and physician prescribing in order to determine whether evidence is sufficient to conclude that payments cause physicians to change their prescribing practices across a broad range of  medical specialties and drug types.
Dr. Jeffrey Drebin
Spotlight on Pancreatic Cancer Treatment and Research
With notable cases of pancreatic cancer in the news this year, MSK held an Information Session for Patients and Caregivers with the goal of helping people understand the disease and sharing some of the encouraging breakthroughs in research and treatment.
Ask the Expert
Black male conferring with female doctor in scrubs.
4 Things African American Men Should Know about Prostate Cancer
Learn why African American men should be especially mindful of prostate cancer risk.